mailed
on 09 Apr 2024
Last Applicant/ Owned by
2828 S Corbett Avenue
Portland
OR
97201
Serial Number
97822597 filed on 03rd Mar 2023
Registration Number
N/A
Correspondent Address
Lisa M. Caldwell
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIOSCIENCES"
"BIOSCIENCES" Color is not claimed as a feature of the mark. Drug delivery agents in the form of compounds, tablets, capsules, powders, dissolvable films, or liquids that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of wide range of pharmaceuticals; drug delivery agents consisting of compounds that improve the eRead More
Drug delivery agents in the form of compounds, tablets, capsules, powders, dissolvable films, or liquids that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of wide range of pharmaceuticals; drug delivery agents consisting of compounds that improve the efficacy of other drug delivery agents, all to facilitate the delivery of a wide range of pharmaceuticals; pens; adhesive note pads; mugs; t-shirts
No 97822597
No Service/Collective Mark
No 104131095011
No
No
No
No
No
No
No
No
26.01.03 -
Incomplete circles (more than semi-circles)
26.01.21 -
Circles that are totally or partially shaded
26.01.30 -
Four Circles
The mark consists of semi-complete circles containing three shaded circles of varying sizes inside with the stylized wording "ENDOREL BIOSCIENCES".
| Status Date | Action Taken |
|---|---|
| 09th Apr 2024 | FINAL REFUSAL WRITTEN |
| 09th Apr 2024 | FINAL REFUSAL E-MAILED |
| 09th Apr 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 14th Mar 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 14th Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 14th Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 15th Dec 2023 | NON-FINAL ACTION WRITTEN |
| 15th Dec 2023 | NON-FINAL ACTION E-MAILED |
| 15th Dec 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 01st Dec 2023 | ASSIGNED TO EXAMINER |
